Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Australia: Omnibus claims and the doctrine of equivalents

For many years, Australia has allowed omnibus claims, which take the form of "an apparatus substantially as hereinbefore described…". They have been utilised as a last line of defence for patentees when suing defendants.

Unfortunately, Australia does not have a strong doctrine of equivalence, found for example, in US jurisprudence. Hence, we have tended towards a literal infringement of claims.

Any hope that the omnibus claim would assist in finding non-literal infringement of patent applications has recently been dashed by our Full Federal Court in GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser Healthcare (UK) Ltd [2016] FCAFC 90.

The subject matter of the case dealt with a spill-free syringe dispensing system, which dominated the consumer market. The defendants had invented around the main claim and had developed an alternate syringe that the trial judge found had "exactly the same function". Unfortunately, for the patentee, the defendant's modifications meant that there was no literal infringement of the main claims.

The trial judge held that the omnibus claim could be utilised in a doctrine of equivalence sense to cover the "substance" of the invention. The Full Court overruled the trial judge, and, as a result, severely curtailed the operation of omnibus claims. The Court noted the overriding requirement for the omnibus claim to not extend beyond what was covered by the claims.

As a consequence, omnibus claims (which have recently also been curtailed by our Patents Act), are significantly reduced in effectiveness. Also, our courts appear to be moving towards a literal infringement position of patent claims which will be of great concern to patentees.


Peter Treloar

Shelston IPLevel 21, 60 Margaret StreetSydney NSW 2000, AustraliaTel: +61 2 9777 1111Fax: +61 2 9241

more from across site and ros bottom lb

More from across our site

The easyJet owner’s trademark complaint says the band Easy Life has risked damage to the airline’s reputation through negative publicity
Jessica Kaiser tells Managing IP why she moved to Perkins Coie and how she wants to expand the firm’s PTAB practice
Lawyers at Allen & Overy provide some key takeaways from the UPC’s first few months
Speaking exclusively to Managing IP, Oliver Walsh said he is looking forward to developing cutting-edge enforcement solutions, including AI-powered predictive analysis
Johnson & Johnson won’t enforce patents for bedaquiline after months of public scrutiny and new licences for generics
We have published this year’s Corporate IP Stars list, an annual rankings publication which recognises senior in-house practitioners
The 2023 edition of Managing IP’s Rising Stars publication is now available online
Allison M Hester, attorney at Moye White, outlines Mattel's litigation history and explains what trademark lessons brands can learn from the toy company
The former BoA president won a high-profile race to succeed Christian Archambeau as executive director in July
Each week Managing IP speaks to a different IP professional about their life and career